跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 578 条关于
“BCME”
全部
578
临床试验
310
药物
224
机构
3
资讯
41
9个月前
Vaximm Secures Potential $835M Deal with BCM Europe for Oral Cancer Immunotherapy Platform VXM01
10个月前
OSR Holdings Subsidiary Vaximm Secures $835M Licensing Deal for Oral Cancer Immunotherapy VXM01
8年前
GSK's BCMA-Targeting ADC, GSK2857916, Receives FDA Breakthrough Therapy Designation for Multiple Myeloma
2年前
CARVYKTI® Approved as First BCMA-Targeted Therapy for Relapsed/Refractory Multiple Myeloma After One Prior Line
2年前
Poseida's Allogeneic CAR-T Therapy P-BCMA-ALLO1 Shows High Response in Myeloma
2年前
P-BCMA-ALLO1 Granted FDA RMAT Designation for Relapsed/Refractory Multiple Myeloma
去年
Regeneron Secures FDA Approval for BCMA-Targeted Bispecific Antibody in Multiple Myeloma
11个月前
IASO Bio Receives Japanese Regulatory Approval for BCMA CAR-T Clinical Trial
去年
Talquetamab Shows Promise in Relapsed/Refractory Multiple Myeloma, Including Post-BCMA Failure
9个月前
Baseline Blood Parameters Predict BCMA CAR-T Therapy Outcomes in Multiple Myeloma Patients
第 1 页,共 5 页
上一页
下一页